Children and adults aged 9 years or older with a diagnosis of seborrheic dermatitis, may qualify to participate. Individuals must have mild to moderate seborrheic dermatitis with involvement of 20% or more body surface area (BSA). A history of seborrheic dermatitis for at least 3 months is required along with stable disease for the past 4 weeks with no significant flares, before screening.
Participants will receive investigational topical medication (active study drug) or placebo, via a foam. Study medication and study-related care will be provided at no cost. Reimbursement for study-related expenses will also be provided.
Study participation will last about 8 weeks and involve about 5 visits to the study centre.